Drug Trial Radar · NCT03362177
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
Last checked: Nov 20, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
165
Actual
Start
Sep 30, 2019
Primary completion
Jan 25, 2024
Study completion Jan 9, 2025
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Dec 5, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects with Gastrointestinal, Pancreatic, or Colorectal Cancer
Conditions
- Chemotherapy-induced Thrombocytopenia
Interventions
RomiplostimBiological
This study is designed to study Romiplostim for the treatment of chemotherapy-induced thrombocytopenia (CIT) in patients receiving chemotherapy for the treatment of gastrointestinal/colorectal/pancreatic cancer.
PlaceboOther
Placebo Comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Had Thrombocytopenia-induced Dose ModificationTime frame: Day 1 up to Week 12
Locations
117 sites in 20 countries. Site status is shown where the registry gives one.
Saint Bernards Medical Center
Jonesboro, Arkansas
Pacific Cancer Medical Center Inc
Anaheim, California
University of California Irvine
Orange, California
Colorado West Healthcare System dba Grand Valley Oncology
Grand Junction, Colorado
Mid Florida Hematology and Oncology Centers PA
Orange City, Florida
Oncology and Hematology Associates of West Broward, PA
Tamarac, Florida
Cleveland Clinic Florida
Weston, Florida
Orchard Healthcare Research Inc
Skokie, Illinois
Christus Saint Frances Cabrini Hospital
Alexandria, Louisiana
University Medical Center New Orleans
New Orleans, Louisiana
Christus Highland Cancer Treatment Center
Shreveport, Louisiana
Mercy Medical Center
Baltimore, Maryland
American Oncology Partners, PA
Bethesda, Maryland
Massachusetts General Hospital Cancer Center
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Hattiesburg Clinic Hematology/Oncology
Hattiesburg, Mississippi
Oncology Hematology Associates
Springfield, Missouri
Morristown Medical Center
Morristown, New Jersey
Regional Cancer Care Associates
Sparta, New Jersey
The Center for Cancer and Blood Disorders
Fort Worth, Texas
Medical Oncology Associates PS
Spokane, Washington
Yakima Valley Memorial Hospital
Yakima, Washington
Centro de Diagnostico Investigacion y Tratamiento
Salta, Argentina
Hospital Universitario Fundacion Favaloro
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Instituto Oncologico Cordoba
Córdoba, Córdoba Province, Argentina
Centro de Investigaciones Clínicas Clínica Viedma
Viedma, Río Negro Province, Argentina
Landeskrankenhaus Steyr
Steyr, Austria
Universitaetsklinikum Allgemeines Krankenhaus Wien
Vienna, Austria
Instituto de Oncologia do Parana
Curitiba, Paraná, Brazil
Vencer e Oncoclinica
Teresina, Piauí, Brazil
Centro de Pesquisa da Serra Gaucha - Cepesg
Caxias do Sul, Rio Grande do Sul, Brazil
Catarina Pesquisa Clinica
Itajaí, Santa Catarina, Brazil
Loema Instituto de Pesquisa Clinica e Consultores Ltda
Campinas, São Paulo, Brazil
Casa de Saude Santa Marcelina
São Paulo, São Paulo, Brazil
Complex Oncology Center - Ruse EOOD
Rousse, Bulgaria
Medical Center Nadezhda Clinical EOOD
Sofia, Bulgaria
Specialized Hospital for Active Treatment of Oncology EAD
Sofia, Bulgaria
Cape Breton Cancer Centre, Nova Scotia Health Authority
Sydney, Nova Scotia, Canada
Grand River Regional Cancer Centre at Grand River Hospital
Kitchener, Ontario, Canada
Fundacion Colombiana de Cancerologia Clinica Vida
Medellín, Antioquia, Colombia
Showing 40 of 117 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.